Skip to main content

Table 1 Plan characteristic distributions

From: Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics

Characteristics

Plan number (%)

Plan type

 

 IMRT

298 (43.4%)

 VMAT

389 (56.6%)

Treatment site

 

 Head and neck

182 (26.5%)

 Chest and breast

161 (23.4%)

 Pelvic cavity and Abdomen

344 (50.1%)

Gamma passing rate

 

 60 − 80%

95 (13.8%)

 80 − 90%

92 (13.4%)

 90 − 95%

120 (17.5%)

 95 − 100%

380 (55.3%)